These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23640051)

  • 1. Increasing the degrees of freedom in future group randomized trials: the df * method revisited.
    Murray DM; Blitstein JL; Hannan PJ; Shadish WR
    Eval Rev; 2012 Dec; 36(6):430-48. PubMed ID: 23640051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing the degrees of freedom in future group randomized trials: the df* approach.
    Blitstein JL; Murray DM; Hannan PJ; Shadish WR
    Eval Rev; 2005 Jun; 29(3):268-86. PubMed ID: 15860766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing the degrees of freedom in existing group randomized trials: the df* approach.
    Blitstein JL; Hannan PJ; Murray DM; Shadish WR
    Eval Rev; 2005 Jun; 29(3):241-67. PubMed ID: 15860765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic examination of the citation of prior research in reports of randomized, controlled trials.
    Robinson KA; Goodman SN
    Ann Intern Med; 2011 Jan; 154(1):50-5. PubMed ID: 21200038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and analysis of group-randomized trials in cancer: a review of current practices.
    Murray DM; Pals SL; Blitstein JL; Alfano CM; Lehman J
    J Natl Cancer Inst; 2008 Apr; 100(7):483-91. PubMed ID: 18364501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical assessment suggests that existing evidence could be used more fully in designing randomized controlled trials.
    Goudie AC; Sutton AJ; Jones DR; Donald A
    J Clin Epidemiol; 2010 Sep; 63(9):983-91. PubMed ID: 20573483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How many do I need? Basic principles of sample size estimation.
    Devane D; Begley CM; Clarke M
    J Adv Nurs; 2004 Aug; 47(3):297-302. PubMed ID: 15238124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials.
    Diehr P; Chen L; Patrick D; Feng Z; Yasui Y
    Contemp Clin Trials; 2005 Feb; 26(1):45-58. PubMed ID: 15837452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of randomized controlled trials: issues to consider when designing a trial.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2013 Jun; 143(6):905-7. PubMed ID: 23726342
    [No Abstract]   [Full Text] [Related]  

  • 11. Sample-size requirements for comparisons of two groups on repeated observations of a binary outcome.
    Leon AC
    Eval Health Prof; 2004 Mar; 27(1):34-44. PubMed ID: 14994558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample-size calculations for studies with correlated ordinal outcomes.
    Kim HY; Williamson JM; Lyles CM
    Stat Med; 2005 Oct; 24(19):2977-87. PubMed ID: 16149125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of multiregional trials with heterogeneous treatment effect across regions.
    Chen CT; Hung HM; Hsiao CF
    J Biopharm Stat; 2012 Sep; 22(5):1037-50. PubMed ID: 22946948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A priori power analysis in longitudinal three-level multilevel models: an example with therapist effects.
    de Jong K; Moerbeek M; van der Leeden R
    Psychother Res; 2010 May; 20(3):273-84. PubMed ID: 19946814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing quality of reports on randomized clinical trials in nursing journals.
    Parent N; Hanley JA
    Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting through the statistical fog: understanding and evaluating non-inferiority trials.
    Weintraub WS
    Int J Clin Pract; 2010 Sep; 64(10):1359-66. PubMed ID: 20716144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trials for the real world: making as few and as reasonable assumptions as possible.
    Baker SG; Kramer BS
    Stat Methods Med Res; 2008 Jun; 17(3):243-52. PubMed ID: 17925312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in worldwide volume and methodological quality of surgical randomized controlled trials.
    Ahmed Ali U; van der Sluis PC; Issa Y; Habaga IA; Gooszen HG; Flum DR; Algra A; Besselink MG
    Ann Surg; 2013 Aug; 258(2):199-207. PubMed ID: 23774315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
    Kikuchi T; Gittins J
    Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.